Federal standards, employer preparedness plans need improving to protect frontline workers: study … Joint federal agency letter urges utility data access for affordable housing providers … LeadingAge...
Differences ID’d in tau burden in Down syndrome, Alzheimer’s disease
Apr 25, 2024
Differences in spatial distribution, timing and magnitude of tau burden were seen for two genetic forms of Alzheimer’s disease.
Bill calls for $165 million in funding for Alzheimer’s-related initiatives
By
Kimberly Bonvissuto
Feb 12, 2024
Bipartisan bills recently introduced in the US Senate and House of Representatives, if passed as written and signed into law, would fund public health initiatives related to Alzheimer’s disease to the...
High risk for psychiatric disorders seen before dementia diagnosis
Oct 20, 2023
The findings were consistent regardless of dementia subtype.
Hippocampal atrophy linked to cognitive decline in older adults
Nov 17, 2023
The association was independent of Aβ and tau and accounted for 10% of the variance in cognitive decline.
Lower Alzheimer’s risk seen with PDE5i initiation for erectile dysfunction
Feb 08, 2024
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
Stress, depression linked to MCI, Alzheimer’s disease
Oct 20, 2023
Chronic stress and depression are independent risk factors and have an additive effect when combined.
More news for Friday, March 1
By
Kimberly Bonvissuto
Mar 01, 2024
What states spent on dementia care in 2010 through 2019 … Impaired sense of direction may be early sign of Alzheimer’s … Experiencing low healthcare quality is associated with greater dementia risk...
Neurological conditions ranked as leading cause of disability-adjusted life years globally
Mar 15, 2024
Between 1990 and 2021, there was an 18.2 percent increase in the global DALY counts attributed to those conditions
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.